Literature DB >> 32085055

Pembrolizumab with or without chemotherapy versus chemotherapy for first-line treatment of advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The Phase 3 KEYNOTE-062 Study.

J Tabernero1, E Van Cutsem2, Y Bang3, C Fuchs4, L Wyrwicz5, K Lee6, I Kudaba7, M Garrido8, H Chung9, H Castro Salguero10, W Mansoor11, M Braghiroli12, E Goekkurt13, J Chao14, Z Wainberg15, U Kher16, S Shah16, S Kang16, K Shitara17.   

Abstract

Year:  2019        PMID： 32085055     DOI： 10.1093/annonc/mdz183.001

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  1 in total

Review 1.  Esophageal, gastric cancer and immunotherapy: small steps in the right direction?

Authors:  Adam Zayac; Khaldoun Almhanna
Journal:  Transl Gastroenterol Hepatol       Date:  2020-01-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.